Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

Purification of Hclec-2 Recombinant Protein in Engineering Bacteria and Preparation and Identification of Its Antibody

Expression,purification and preparation of monoclonal antibody of HCA518 protein

[Expression, purification and polyclonal antibody preparation of GST-Ccd1 fusion protein]

Preparation and Identification of Monoclonal Antibody Against Cytolysin of Vibrio Vulnificus

[Preparation and Identification of Polyclonal Antibody Against Cysteinyl Leukotriene Receptor 2].

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

The Production of Soluble C-type Lectin-Like Receptor 2 is a Regulated Process

Preparation of monoclonal antibodies against C-type lectin receptors Dectin-2 and Dectin-3

Expression of Hepatitis C Virus E2 Ectodomain in E. Coli and Its Application in the Detection of Anti-E2 Antibodies in Human Sera

[Preparation and Identification of the Polyclonal Antibody Against Extracellular Domain (405T-573Q) of Rat Toll-like Receptor 2].

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

Advances on the Study of CLEC-2, a New C-type Lectin Receptor

Prokaryotic expression and polyclonal antibody preparation of human novel gene CTRP4]

Purification of A Polyclonal Antibody Against Cd147 for Elisa Using Antigen-Immunoaffinity Chromatography

Cloning, Expression, Separation and Purification of Particle-Like Protein Loading CETP Polypeptide Epitopes

[Expression and Purification of Human Recombinant LC3 in E.coli and Preparation of Its Polyclonal Antibodies].

Prokaryotic expression, purification and preparation of polyclonal antibody for human UNC5CL]

Recombinant protein expression and monoclonal antibody preparation of HCCR

Production and Identification of Monoclonal Antibodies to Chcd25

Molecular characterization of two novel isoforms and a soluble form of mouse CLEC-2.

Preparation of Anti-LeERF2 Polyclonal Antibody